Rapamycin is a drug originally discovered in soil bacteria on Easter Island, known for its ability to inhibit a protein called mTOR, which is involved in cell growth and metabolism. In studies on mice, rapamycin has demonstrated the ability to extend lifespan and improve health by reducing age-related diseases and enhancing the body’s response to stress. This mechanism of action has sparked interest in geroscience, particularly in how it might be applied to promote longevity and quality of life in dogs. For canine longevity, researchers are exploring how rapamycin and similar compounds can help address common age-related conditions in dogs, such as arthritis, cancer, and cognitive decline. While research is still in its early stages, the idea is that by modulating cellular processes associated with aging, we may be able to improve health outcomes in our canine companions. This line of inquiry is particularly exciting for dog owners who wish to enhance their pets' quality of life as they age, potentially leading to longer, healthier lives for their furry friends.